https://wiki.stamen.health/index.php?action=history&feed=atom&title=Mode_Sensors 2026-04-15T01:21:58Z Revision history for this page on the wiki MediaWiki 1.42.7 https://wiki.stamen.health/index.php?title=Mode_Sensors&diff=656&oldid=prev 2026-04-14T20:14:53Z

<p>Created with researched data</p> <p><b>New page</b></p><div>{{DISPLAYTITLE:Mode Sensors}}<br /> {{Infobox company<br /> | name = Mode Sensors AS<br /> | org_number = 816650402<br /> | founded = 2016-01-22<br /> | employees = 10<br /> | address = Norway<br /> | industry = 72.100 – Biotechnology research<br /> | website = https://www.modesensors.com<br /> | nht_category = Startup<br /> | description = Mode Sensors develops Re:Balans, an FDA-cleared medical-grade wearable for non-invasive real-time fluid monitoring. The device addresses fluid management — a critical clinical challenge in heart failure, kidney disease, and general hospital monitoring. The company also has a US market focus.<br /> | notes = 10 employees. FDA clearance is a significant regulatory milestone. Fluid monitoring for heart failure is a large market with high unmet need.<br /> | related_companies = [[Invivo Bionics]], [[GlucoSet]], [[Cardiaccs]], [[Norway Health Tech]]<br /> | categories = Norway Health Tech, Startups, Wearables, Medical Devices, Cardiovascular, Remote Monitoring<br /> | sources = https://www.modesensors.com; https://data.brreg.no/enhetsregisteret/api/enheter/816650402<br /> }}<br /> <br /> == About ==<br /> <br /> Mode Sensors AS is a Norwegian medical technology company developing wearable monitoring solutions for fluid management in clinical settings. Founded in 2016 with 10 employees.<br /> <br /> == Product ==<br /> <br /> === Re:Balans ===<br /> <br /> Re:Balans is an FDA-cleared medical-grade wearable device for non-invasive, real-time fluid monitoring. Key features:<br /> <br /> * Non-invasive measurement of fluid status<br /> * Real-time monitoring capability<br /> * Medical-grade accuracy<br /> * US market clearance (FDA)<br /> <br /> == Clinical Need ==<br /> <br /> Fluid overload (hypervolemia) and dehydration (hypovolemia) are common clinical challenges in:<br /> * Heart failure patients<br /> * Kidney disease patients<br /> * Post-operative patients<br /> * General hospital ward monitoring<br /> <br /> Current methods for assessing fluid status (weight, physical exam, invasive central venous pressure) are imprecise or risky. A non-invasive wearable that continuously monitors fluid status addresses a significant clinical gap.<br /> <br /> == Market Position ==<br /> <br /> FDA clearance is a significant achievement and regulatory milestone. The US market focus indicates commercial ambition beyond Norway. Heart failure affects approximately 64 million people globally, representing a large addressable market.<br /> <br /> == References ==<br /> &lt;references/&gt;<br /> <br /> [[Category:Norway Health Tech]]<br /> [[Category:Startups]]<br /> [[Category:Wearables]]<br /> [[Category:Medical Devices]]<br /> [[Category:Cardiovascular]]<br /> [[Category:Remote Monitoring]]</div>

Admin 3julmthh